REG - Sunplus Technology - Final Results

Sunplus Technology CoAnnouncement

31/03/2020 07:01

RNS Number : 1465I
  
Sunplus Technology Co Limited
  
31 March 2020
  
 

Sunplus Technology Company Limited
Consolidated Balance Sheets
Ended December 31, 2019*
(In Thousands of New Taiwan Dollars)
 



Assets


Amount


Liabilities & Shareholders Equity


Amount




Cash & Equivalent


3,020,628


Current Liabilities


1,342,416




Financial assets at fair value through profit or loss-current  


1,090,679


Non-Current Liabilities


574,660




Accounts & Notes receivable


832,633


Total Liabilities


1,917,076




Other Receivable


28,159


Equity attributable to owners of the parent








Inventories


759,211


Capital stock


5,919,949




Other current assets


208,837


Shares to be issued 








Total Current Assets


5,940,147


Capital surplus


594,432












Appropriated as legal reserve


1,942,388




Financial assets at fair value through profit or loss - non-current


1,027,445


Appropriated as special reserve


308,452




Financial assets at fair value through other comprehensive income - non-current


189,387


Unappropriated earnings (deficit)


(262,261)




Investments accounted for using the equity method


695,028


Others


(261,026)




Property, plant and equipment


1,968,803


Treasury Stock


(63,401)




Right-of-use asset


241,914


Total equity attributable to owners of the parent


8,178,533




Investment properties


1,066,797












Intangible Assets-Net


176,233


Non-Controlling Interests


1,394,158




Deferred tax assets


28,754


Total Shareholders¡¦ Equity


9,572,691




Net defined benefit asset, non-current


1,163












Other Non-Current Assets


154,096












Total Non-Current Assets


5,549,620












Total Assets


        11,489,767


Total Liabilities & Shareholders' Equity


11,489,767







 
Sunplus Technology Company Limited
Consolidated Statements of Income
From January 1 to December 31, 2019 and 2018
(In Thousands of New Taiwan Dollars, Except Earnings per share) 



Unit: NT$K, Except EPS


2019


2018


YoY




Net sales


5,512,330


6,077,733


(9.30)




Cost


3,137,755


3,648,349


(14.00)




Gross Profit


2,374,575


2,429,384


(2.26)




  Marketing Expense


263,373


286,562


(8.09)




  General& Administrative Expense


498,466


532,943


(6.47)




R&D Expenses


1,481,269


1,699,345


(12.83)




Expected credit gain on reversal


(73)


-


-




Other operating income(Expense)


201


(324)


(162.04)




Total operating income (expense)


131,741


(89,790)


(246.72)




Total non-operating income (expense)


112,479


293,780


(61.71)




Income(loss) before income tax from continued operating units


244,220


203,990


19.72




Income tax expense


69,468


61,667


12.65




Consolidated Net Income


174,752


142,323


22.79




Consolidated Net Income

Attributable To Shareholders of the parent


15,309


5,616


172.60




Consolidated Earnings Per Share NT$ Attributable To Shareholders of the parent*


0.03


0.01







* Based on outstanding 588,434,923 shares on 2019/12/31




Sunplus Technology Company Limited
Consolidated Cash Flow Summary
From January 1 to December 31, 2019 and 2018
(In Thousand New Taiwan Dollars)
 



ITEM


2019


2018




Cash Flow in (out) from operating


651,653


283,919




Cash Flow in (out) from Investing


(241,377)


(313,311)




Cash Flow in (out) from Financing


(623,191)


(895,040)




Impact from Fx Change


(2,178)


3,876




Net Increase (Decrease) in Cash & Cash Equivalents


(215,093)


(920,556)




Cash & Cash Equivalents, Beginning of Period


3,235,721


4,156,277




Cash & Cash Equivalents, End of Period


3,020,628


3,235,721



 
 




Spokesman
Wayne Shen
Tel: +886-3-5786005 ext. 2350
E-mail: wayne@sunplus.com
 


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
FR UAORRRUUOORR